caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1376624346

Janna OsorioMD

PRACTICESHARP HEALTHCARESee all providers at this practice →
Family PracticeChula Vista, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Janna Osorio's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Sharp Healthcare
Clinical Laboratory · San Diego, CA
1320
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Sharp Healthcare
Clinical Laboratory · Chula Vista, CA
45132
Sharp Healthcare
Clinical Laboratory · San Diego, CA
41102
Sharp Healthcare
Clinical Laboratory · Chula Vista, CA
1535
Barry Lumkin
Diagnostic Radiology · San Diego, CA
1322
SHARP CHULA VISTA MEDICAL CENTER1122
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
143
Unique beneficiaries
—
Total services
199
Distinct HCPCS
4
Medicare payment
$13K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 8,228 Family Practice providers in CA — below median (cohort median 411).
PRESCRIBING · PART D · 2024
Total Rx claims
3,617
Beneficiaries
—
Total drug cost
$349K
Distinct drugs
70
Brand share
15.7%
Top prescribed drugs
Atorvastatin Calcium461 claims
Lisinopril212 claims
Rosuvastatin Calcium182 claims
Losartan Potassium182 claims
Omeprazole180 claims
QUALITY · MIPS · 2024
Final MIPS score
88.7
Quality
81.0
Cost
82.0
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.58%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.